Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP73603.RAd-EtU3N_98Xme8s287EWr-5_c5NbiANlOqsQgqPmva0130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73603.RAd-EtU3N_98Xme8s287EWr-5_c5NbiANlOqsQgqPmva0130_provenance.
• NP85458.RAAQdesYL0-qzfFMFvtiWoT1NwcEyax3fTN2cxL4wMokA130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85458.RAAQdesYL0-qzfFMFvtiWoT1NwcEyax3fTN2cxL4wMokA130_provenance.
• NP85461.RA6IpTbNiRrhcpbJZubCZuKPuyeECzQ0vWGuzs2RKQscg130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85461.RA6IpTbNiRrhcpbJZubCZuKPuyeECzQ0vWGuzs2RKQscg130_provenance.
• NP85466.RA7IkIX_wtKyGRX_GVyhFZ1AXuHrwYXHlHdI8D-PSFHBE130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85466.RA7IkIX_wtKyGRX_GVyhFZ1AXuHrwYXHlHdI8D-PSFHBE130_provenance.
• NP85472.RA6xHZh93EBwKbxKuqrZMHJF1GXsk5JkTQ2X0PWAKHjNA130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85472.RA6xHZh93EBwKbxKuqrZMHJF1GXsk5JkTQ2X0PWAKHjNA130_provenance.
• NP85492.RAwo8t4Pgag8-cbgfJW7Ox3ACDMFddQskyf7tKqyTxQgc130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85492.RAwo8t4Pgag8-cbgfJW7Ox3ACDMFddQskyf7tKqyTxQgc130_provenance.
• NP90752.RA6lVgUuvzYUZ9h0SpgnbpMY93NOZUOhYfgr2o0dizNz0130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90752.RA6lVgUuvzYUZ9h0SpgnbpMY93NOZUOhYfgr2o0dizNz0130_provenance.
• NP85453.RAZAQGsYb6VPnEEwsdWs9EFx9GUReGuim0uzHJhY6ONZg130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85453.RAZAQGsYb6VPnEEwsdWs9EFx9GUReGuim0uzHJhY6ONZg130_provenance.
• NP85462.RAYTXkNdJg_Aa-wLXhdP76VIOC2zz1cQFrDKPXxWSHLIc130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85462.RAYTXkNdJg_Aa-wLXhdP76VIOC2zz1cQFrDKPXxWSHLIc130_provenance.
• NP85478.RATKmDIeqWM2fK_kVTbalTYr26_y6iQOyNhFhL7Fi6pRY130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85478.RATKmDIeqWM2fK_kVTbalTYr26_y6iQOyNhFhL7Fi6pRY130_provenance.
• NP85484.RAdNbNfXk4lOgdpJItALo_AdcsD44O9PcdNwkweZ1UIT0130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85484.RAdNbNfXk4lOgdpJItALo_AdcsD44O9PcdNwkweZ1UIT0130_provenance.
• NP85447.RAKmZykaH5BFGssbgHSpTKGxIxmonHSmiOtrFp6zjPJVE130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85447.RAKmZykaH5BFGssbgHSpTKGxIxmonHSmiOtrFp6zjPJVE130_provenance.
• assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP103632.RAYwkFohrtvHYBimnEF9FIRi2PCHfPJTlDUe05vCkn-aE130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP103632.RAYwkFohrtvHYBimnEF9FIRi2PCHfPJTlDUe05vCkn-aE130_provenance.
• NP133043.RASmZaGXWb1dsaFpOgykm9MeXeqbtWmpb49rsG-R0UfeI130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133043.RASmZaGXWb1dsaFpOgykm9MeXeqbtWmpb49rsG-R0UfeI130_provenance.
• NP133102.RAXf_6XPSFivFDs1xmNpaAOP4PcWBOhfDJ_rhBTHnzdBc130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133102.RAXf_6XPSFivFDs1xmNpaAOP4PcWBOhfDJ_rhBTHnzdBc130_provenance.
• assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP133032.RAmvXxVb7PRQ5EJrOWPMS3vRard_nEkq9dfQfEZyAd0c8130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133032.RAmvXxVb7PRQ5EJrOWPMS3vRard_nEkq9dfQfEZyAd0c8130_provenance.
• NP133147.RADjdSONfdtcphkeqN_-vg23J52y888g9wLtzeIDO4lvc130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133147.RADjdSONfdtcphkeqN_-vg23J52y888g9wLtzeIDO4lvc130_provenance.
• NP181872.RAf33cRjuyUWOykqL-BSHo3agowRJGuFTX1nbGsy4aQjs130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181872.RAf33cRjuyUWOykqL-BSHo3agowRJGuFTX1nbGsy4aQjs130_provenance.
• NP181877.RAWRP7RWKmCWYRG3bd2yTtD9ckPaottqvsYI4ba9cyIBg130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181877.RAWRP7RWKmCWYRG3bd2yTtD9ckPaottqvsYI4ba9cyIBg130_provenance.
• assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP826982.RASQeTjIfy1HMtq_rCtVN3_9yg90an4nIWK3oiyEagEkk130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826982.RASQeTjIfy1HMtq_rCtVN3_9yg90an4nIWK3oiyEagEkk130_provenance.
• NP452340.RAmXsD8STUEbqeq9ZaEPhUDgWdUyU1q9CreUScwjLFXtA130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452340.RAmXsD8STUEbqeq9ZaEPhUDgWdUyU1q9CreUScwjLFXtA130_provenance.
• NP181870.RAry_J54B1KU7l4FtgM1OKBktNZjTBzc2K8VwvFvD4L78130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181870.RAry_J54B1KU7l4FtgM1OKBktNZjTBzc2K8VwvFvD4L78130_provenance.
• NP181876.RAkfz62G6YVrkTbXBatX2mUleJKHpnw-1wJGs9X5f45ZY130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181876.RAkfz62G6YVrkTbXBatX2mUleJKHpnw-1wJGs9X5f45ZY130_provenance.
• NP181879.RAg8MSA_VSzE32M5zjXEI4SHygoBBHVyvRlRh4QfMFhdg130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181879.RAg8MSA_VSzE32M5zjXEI4SHygoBBHVyvRlRh4QfMFhdg130_provenance.
• NP181880.RAnId2Jy4hu7P9vGFZFO96m8T8_gj83DLmsM7R41RmhY4130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181880.RAnId2Jy4hu7P9vGFZFO96m8T8_gj83DLmsM7R41RmhY4130_provenance.
• NP181883.RAmNT53PBU5PdIRTNixqn6aMYTib4l1WP21WJWMlp48u8130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181883.RAmNT53PBU5PdIRTNixqn6aMYTib4l1WP21WJWMlp48u8130_provenance.
• NP132977.RA2adugIBCVg2LMHTtLjsSOydMXmx2gcufv3Q3d-JUQ9g130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP132977.RA2adugIBCVg2LMHTtLjsSOydMXmx2gcufv3Q3d-JUQ9g130_provenance.
• NP133117.RA8e5jucSKTVyN5yEcxtGA0gTQKY9KZfRF73OuQ0SSbrU130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133117.RA8e5jucSKTVyN5yEcxtGA0gTQKY9KZfRF73OuQ0SSbrU130_provenance.
• NP146438.RALHkMNKSWKlxUe_0Gn_1tchj3G4CSRZysy0O5satYFgc130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146438.RALHkMNKSWKlxUe_0Gn_1tchj3G4CSRZysy0O5satYFgc130_provenance.
• NP133000.RALJOfg-FkWzmBLNKrjxkcicq0Ba-cs27P543TzSgtpc4130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133000.RALJOfg-FkWzmBLNKrjxkcicq0Ba-cs27P543TzSgtpc4130_provenance.
• NP133017.RAJ1Ff_f1pU71cnYa1z7V16Aiu2Hkh9uxv8tGvnA4e34s130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133017.RAJ1Ff_f1pU71cnYa1z7V16Aiu2Hkh9uxv8tGvnA4e34s130_provenance.
• NP133061.RAIfrTgqrBdZgoCc7WstEs8iiNK8ZpM2O4vkyGq2L0H6Y130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133061.RAIfrTgqrBdZgoCc7WstEs8iiNK8ZpM2O4vkyGq2L0H6Y130_provenance.
• NP181869.RAPjh1jNOD8Adul1JG8h46QAIq5hScngN60X-Oe-KXsmc130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181869.RAPjh1jNOD8Adul1JG8h46QAIq5hScngN60X-Oe-KXsmc130_provenance.
• NP181875.RAF2LK_hpimUGi-JRrULnhaHvtFRYLfi4yEuA-nF0Lpsw130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181875.RAF2LK_hpimUGi-JRrULnhaHvtFRYLfi4yEuA-nF0Lpsw130_provenance.
• NP181874.RA1A0OF9hbB051kxYiYHxgNdbJv_U4Aply5QHaQoXqBjA130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181874.RA1A0OF9hbB051kxYiYHxgNdbJv_U4Aply5QHaQoXqBjA130_provenance.
• NP181881.RA0aV1uof3BKiJrupxjdpYiZXSRIQE9Vyu8BbtXc5E1Nc130_assertion description "[Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181881.RA0aV1uof3BKiJrupxjdpYiZXSRIQE9Vyu8BbtXc5E1Nc130_provenance.